Investing in the footsteps of Wall Street giants can be a double-edged sword. On one hand, their expertise and resources can lead to lucrative opportunities. On the other hand, differing opinions among analysts can create confusion. Two companies that have garnered attention from Cathie Wood, CEO of a prominent investment management firm, are Block (NYSE: SQ) and Intellia Therapeutics (NASDAQ: NTLA). Both stocks have significant upside potential, according to Wall Street analysts. But should you follow their lead?
Block, despite its 14% year-to-date decline, has shown resilience by posting profits for three consecutive quarters. Its diverse ecosystem, comprising tools for small and medium-sized businesses through Square and its peer-to-peer payment app, Cash App, demonstrates its ability to adapt and grow. However, its reliance on Bitcoin-related revenue creates uncertainty, making it challenging to predict its future performance. With a forward price-to-sales ratio of 1.6 and a forward price-to-earnings ratio of 18.6, Block’s valuation appears reasonable. While it may not reach the Street’s target price of $87.12 in the next year, its long-term prospects look promising.
Intellia Therapeutics, a gene-editing biotech, has sparked interest with its innovative approach. Its leading candidate, NTLA-2001, has the potential to treat transthyretin (ATTR) amyloidosis, a rare disease with no current cure. The company’s pipeline is rich, with multiple candidates in various stages of development. Although Wall Street’s target price of $67.92 implies a substantial upside, it may be overly optimistic, given the risks associated with gene-editing therapies. Intellia’s shares have fallen significantly in recent years, making it a high-risk, high-reward play for investors willing to take on volatility.
Ultimately, investing in Block and Intellia Therapeutics requires careful consideration of their unique challenges and opportunities. While they may not reach the lofty targets set by Wall Street, they possess qualities that could drive long-term growth and success.
Leave a Reply